DGAT2 and hyperlipidemia: Diacylglycerol O-acyltransferase 2 (DGAT2) inhibitors are promising ones aimed at the treatment of metabolic disorders, particularly non-alcoholic steatohepatitis, type 2 diabetes, and hyperlipidemia.